Interferon induced with helicase C domain 1 (IFIH1): Trends on helicase domain and type 1 diabetes onset

Gene

Volumn 516, Issue 1, 2013, Pages 66-68

  Moura, Ronald ^a   Araujo, Jacqueline ^a   Guimarães, Rafael ^a   Crovella, Sergio ^a   Brandão, Lucas ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Autoimmune diseases; Enterovirus response; Genetic susceptibility; Single nucleotide polymorphism

Indexed keywords

HELICASE;

ADOLESCENT; ARTICLE; AUTOIMMUNE THYROIDITIS; CELIAC DISEASE; CONTROLLED STUDY; CRYSTALLOGRAPHY; DISEASE PREDISPOSITION; FAMILY HISTORY; GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON INDUCED WITH HELICASE C DOMAIN 1 GENE; MAJOR CLINICAL STUDY; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ANALYSIS; VIRUS DETECTION; VIRUS ETIOLOGY;

ADOLESCENT; BRAZIL; CELIAC DISEASE; CHILD; DEAD-BOX RNA HELICASES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HASHIMOTO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

ENTEROVIRUS;

EID: 84873095261     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.11.066     Document Type: Article

References (26)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl. 1):S64-S71.
2. Barera G., et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002, 109:833-838.
3. Chistiakov D.A. Interferon induced with helicase C domain 1 (IFIH1) and virus-induced autoimmunity: a review. Viral Immunol. 2010, 23:3-15.
4. Desailloud R., Hober D. Viruses and thyroiditis: an update. Virol. J. 2009, 6:5.
5. Downes K., et al. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS One 2010, 5.
6. Enevold C., Oturai A.B., Sorensen P.S., Ryder L.P., Koch-Henriksen N., Bendtzen K. Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1. J. Neuroimmunol. 2009, 212:125-131.
7. Gonzalez J.R., et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007, 23:644-645.
8. Hyoty H., Taylor K.W. The role of viruses in human diabetes. Diabetologia 2002, 45:1353-1361.
9. Jaidane H., Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab. 2008, 34:537-548.
10. Jun H.S., Yoon J.W. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 2001, 44:271-285.
11. Knip M., Veijola R., Virtanen S.M., Hyoty H., Vaarala O., Akerblom H.K. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005, 54(Suppl. 2):S125-S136.
12. Li Y., et al. Carriers of rare missense variants in IFIH1 are protected from psoriasis. J. Invest. Dermatol. 2010, 130:2768-2772.
13. Nejentsev S., Walker N., Riches D., Egholm M., Todd J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
14. Penna-Martinez M., et al. The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease. BMC Med. Genet. 2009, 10:126.
15. Perros P., McCrimmon R.J., Shaw G., Frier B.M. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet. Med. 1995, 12:622-627.
16. R, C.T. R, a language and environment for statistical computing. Computing 2012, Vienna. R.F.f.S. (Ed.).
17. Salminen K., et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J. Med. Virol. 2003, 69:91-98.
18. Shigemoto T., Kageyama M., Hirai R., Zheng J., Yoneyama M., Fujita T. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J. Biol. Chem. 2009, 284:13348-13354.
19. Smyth D.J., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 2006, 38:617-619.
20. Sutherland A., et al. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J. Clin. Endocrinol. Metab. 2007, 92:3338-3341.
21. Szopa T.M., Titchener P.A., Portwood N.D., Taylor K.W. Diabetes mellitus due to viruses-some recent developments. Diabetologia 1993, 36:687-695.
22. Todd J.A. Etiology of type 1 diabetes. Immunity 2010, 32:457-467.
23. van Belle T.L., Coppieters K.T., von Herrath M.G. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 2011, 91:79-118.
24. van der Werf N., Kroese F.G., Rozing J., Hillebrands J.L. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab. Res. Rev. 2007, 23:169-183.
25. Vasseur E., et al. The selective footprints of viral pressures at the human RIG-I-like receptor family. Hum. Mol. Genet. 2011, 20:4462-4474.
26. Zipris D. Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. Clin. Immunol. 2009, 131:11-23.